Related references
Note: Only part of the references are listed.CSF level of β-amyloid peptide predicts mortality in Alzheimer's disease
Adla Boumenir et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Early Alzheimer-type lesions in cognitively normal subjects
Stergios Tsartsalis et al.
NEUROBIOLOGY OF AGING (2018)
The nonlinear relationship between cerebrospinal fluid A beta(42) and tau in preclinical Alzheimer's disease
Mony J. de Leon et al.
PLOS ONE (2018)
The Effects of Cortical Hypometabolism and Hippocampal Atrophy on Clinical Trajectories in Mild Cognitive Impairment with Suspected Non-Alzheimer's Pathology: A Brief Report
Jun Ku Chung et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
A Review of Fluid Biomarkers for Alzheimer's Disease: Moving from CSF to Blood
Kaj Blennow
NEUROLOGY AND THERAPY (2017)
Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study
Samantha C. Burnham et al.
LANCET NEUROLOGY (2016)
Suspected non-Alzheimer disease pathophysiology - concept and controversy
Clifford R. Jack et al.
NATURE REVIEWS NEUROLOGY (2016)
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
Clifford R. Jack et al.
NEUROLOGY (2016)
Heterogeneity in Suspected Non-Alzheimer Disease Pathophysiology Among Clinically Normal Older Individuals
Elizabeth C. Mormino et al.
JAMA NEUROLOGY (2016)
Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease Pathophysiology
Brian A. Gordon et al.
JAMA NEUROLOGY (2016)
PART, a distinct tauopathy, different from classical sporadic Alzheimer disease
Kurt A. Jellinger et al.
ACTA NEUROPATHOLOGICA (2015)
PART is part of Alzheimer disease
Charles Duyckaerts et al.
ACTA NEUROPATHOLOGICA (2015)
Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage
Stephanie J. B. Vos et al.
BRAIN (2015)
The preclinical phase of the pathological process underlying sporadic Alzheimer's disease
Heiko Braak et al.
BRAIN (2015)
Increased CSF A during the very early phase of cerebral A deposition in mouse models
Luis F. Maia et al.
EMBO MOLECULAR MEDICINE (2015)
Clearance systems in the brain-implications for Alzheimer disease
Jenna M. Tarasoff-Conway et al.
NATURE REVIEWS NEUROLOGY (2015)
Mild cognitive impairment with suspected nonamyloid pathology (SNAP) Prediction of progression
Anna Caroli et al.
NEUROLOGY (2015)
Are cases with tau pathology occurring in the absence of Aβ deposits part of the AD-related pathological process?
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2014)
Primary age-related tauopathy (PART): a common pathology associated with human aging
John F. Crary et al.
ACTA NEUROPATHOLOGICA (2014)
Who Needs Cerebrospinal Biomarkers? A National Survey in Clinical Practice
Anne Cecile Troussiere et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Impact of cerebro-spinal fluid biomarkers of Alzheimer's disease in clinical practice: a multicentric study
Francois Mouton-Liger et al.
JOURNAL OF NEUROLOGY (2014)
Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease
Anne M. Fagan et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Intersite variability of CSF Alzheimer's disease biomarkers in clinical setting
Julien Dumurgier et al.
ALZHEIMERS & DEMENTIA (2013)
CSF biomarker variability in the Alzheimer's Association quality control program
Niklas Mattsson et al.
ALZHEIMERS & DEMENTIA (2013)
Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease
Annapaola Prestia et al.
NEUROLOGY (2013)
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
Bradley T. Hyman et al.
ALZHEIMERS & DEMENTIA (2012)
An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease
Clifford R. Jack et al.
ANNALS OF NEUROLOGY (2012)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
Tero Tapiola et al.
ARCHIVES OF NEUROLOGY (2009)
Beta Amyloid in Alzheimer's Disease: Increased Deposition in Brain Is Reflected in Reduced Concentration in Cerebrospinal Fluid
Timo Grimmer et al.
BIOLOGICAL PSYCHIATRY (2009)
Share Paper
